Jinhe Biotechnology Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinhe Biotechnology Co Ltd with three other
companies in this sector in China:
Guilin Sanjin Pharmaceutical Co Ltd
sales of 1.53 billion Chinese Renmimbi [US$228.71 million]
of which 94%
was Proprietary Chinese medicine),
Shandong Shanda Wit Science and Technology Co Ltd
(1.54 billion Chinese Renmimbi [US$231.49 million]
of which 57%
was Medicines), and
Shanghai Kaibao Pharmaceutical Company Limited
(1.50 billion Chinese Renmimbi [US$224.50 million]
of which 100%
Jinhe Biotechnology Co Ltd reported sales of 1.50 billion Chinese Renmimbi (US$224.22 million)
December of 2016.
increase of 19.6%
versus 2015, when the company's sales were 1.25 billion Chinese Renmimbi.
This was the third consecutive year of growth at Jinhe Biotechnology Co Ltd.